Group Brochure

Feedback

RSS Feed

From proteomics to molecular diagnostics, innovations in biotechnology and pharmaceuticals have amplified the need for intellectual property counsel who understand both the science and the competitive position of our clients’ businesses. With the diverse talents and backgrounds of our attorneys, Brinks is ideally positioned to counsel clients as varied as small start-ups, prestigious academic institutions and global corporations on the ever-evolving body of law promoting and protecting innovation in the United States and throughout the world.

Many of our biotechnology and pharmaceutical attorneys and agents hold advanced degrees in fields such as organic chemistry, biophysics, molecular biology, genetics and pharmacology. Brinks attorneys are also highly skilled in drafting and prosecuting patent applications in fields as varied as gene therapy, genetic microarrays and tissue engineering. We battle in USPTO interferences to determine priority for world-changing inventions in fields such as transgenic corn and gene therapy and have helped bring technologies and business together by crafting licenses and other agreements from drug discovery to genetic microarrays and beyond. Brinks attorneys continue to fight for high technology in the courts as well, most recently in the prominent Federal Circuit case involving the written description and enablement requirements of antibody inventions.